ASX ANNOUNCEMENT ACTIVITY REPORT AND CASH FLOW REPORT FOR THE QUARTER ENDED 30 SEPTEMBER 2026 Highlights: ? NMSC Trial Progression to Ph II: All patient treatments were completed with recruitment closed in Ph I trial; preliminary data from 14 patient readouts showed no adverse events related to...